0.65
+0.0005(+0.08%)
Currency In USD
Address
4040 Macarthur Boulevard
Newport Beach, CA 92614
United States of America
Phone
949-354-6499
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
July 24, 2023
| Name | Title | Pay | Year Born |
| Mr. Marc Forth | Principal Financial Officer, President, Chief Executive Officer & Director | 948,750 | 1971 |
| Mr. Alex Wilson | Executive Vice President, Chief Legal Officer & Corporate Secretary | 517,397 | 1987 |
| Dr. Chad K. Oh M.D. | Chief Medical Officer | 561,000 | 1959 |
| Ms. Jennifer Sy | Principal Accounting Officer | 0 | 1985 |
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.